Mylan lowers outlook after Q2 earnings, sales miss estimates

Mylan lowers outlook after Q2 earnings, sales miss estimates

Source: 
Drug Delivery Business News
News Tags: 
snippet: 

Shares in Mylan (NSDQ:MYL) fell today after the pharmaceutical company missed expectations on Wall Street with its second-quarter financial results.